USA Project - CCA waste

RNS Number:7117D
Virotec International PLC
12 September 2007

                           VIROTEC INTERNATIONAL PLC

12 September 2007

                     USA Project for Treatment of CCA Waste


The Directors of Virotec International plc ("Virotec") (AIM:VTI) are pleased to
announce that it has been awarded a contract for $US157,000 for the in-situ
ViroFlow(TM)Technology treatment of residual arsenic in groundwater at a
Superfund site in California, USA.

The site is a former wood preserving site where Copper Chrome Arsenate ("CCA")
treatment has been used, and the contract follows extensive trials and a review
and approval of the in-situ treatment Work Plan by the U.S. Environmental
Protection Agency (EPA) Region 9. Virotec considers that this is a significant
contract as there are more than 40 sites under the auspices of EPA Region 9 with
arsenic contamination in the soil, and the EPA's approval of this project is the
first for Virotec in California related to arsenic.

CCA is a well-established preservation technique that had been widely used for
several decades until the potential hazards of such treatment became apparent
and is no longer used in some parts of the world. Numerous CCA sites in the U.S.
are now being remediated, mostly by conventional soil excavation and groundwater
pumping, but Virotec's ViroFlowTechnology uses in-situ techniques for arsenic
remediation of groundwater contamination, and complements earlier Virotec
successes in the remediation of residual hexavalent chromium.

Executive Chairman, Brian Sheeran, comments "This project will greatly enhance
our ability to compete for CCA jobs in the USA. It is an area that has been
highly profitable for Virotec in Australia, and with the expertise developed in
Australia we are well placed to become the preferred solution for this problem."


For further information please contact Angus Craig, Company Secretary on +617
5573 3353 or by email at [e-mail].


                           VIROTEC INTERNATIONAL plc
                             Company Number 5796515
                                www.virotec.com






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCLTMBTMMJBMJR